CONVERTIBLE NOTE PAYABLE (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jan. 31, 2026 |
Jan. 31, 2025 |
Oct. 31, 2017 |
|
| Interest expense | $ 65,935 | $ 21,057 | |
| Accrued interest | 83,845 | 39,016 | |
| Gain on debt settlement | $ 2,440,060 | ||
| Shares issued price per share | $ 0.265 | ||
| Convertible Notes Payable [Member] | |||
| Interest expense | $ 14,274 | $ 14,312 | |
| Carrying value of settlement of convertible note | 1,656,213 | ||
| Accrued interest | 117,862 | ||
| Convertible note | $ 1,407,781 | ||
| Gain on debt settlement | 1,123,267 | ||
| Total fair value consideration | $ 532,946 | ||
| Estimated fair value per common share | $ 0.265 | ||
| Shares issued price per share | $ 0.70 | ||
| Common shares issued | 2,011,115 | ||
| Convertible note interest rate | 1.00% | ||
| Convertible note payable debt discount | $ 248,432 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition Fair value amount of life settlement contracts accounted for under the fair value method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Details
|